We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+14.98%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$787M
AUM Growth
+$273M
Cap. Flow
+$216M
Cap. Flow %
27.52%
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.5M
2
NVDA icon
NVIDIA
NVDA
+$9.52M
3
NFLX icon
Netflix
NFLX
+$9.23M
4
GILD icon
Gilead Sciences
GILD
+$7.96M
5
AAPL icon
Apple
AAPL
+$7.69M

Top Sells

Rank Stock Value
1
EDV icon
Vanguard World Funds Extended Duration ETF
EDV
+$3.62M
2
WMT icon
Walmart Inc
WMT
+$2.88M
3
BABA icon
Alibaba
BABA
+$2.64M
4
XYZ
Block Inc
XYZ
+$2.4M
5
INTC icon
Intel
INTC
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 37.36%
2 Healthcare 29.98%
3 Consumer Discretionary 13.6%
4 Communication Services 8.97%
5 Financials 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKFT
351
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$121K 0.02%
3,769
+1,504
+66% +$55.9K
OABI icon
352
OmniAb
OABI
$497M
$121K 0.02%
22,321
+8,871
+66% +$51.1K
OLMA icon
353
Olema Pharmaceuticals
OLMA
$913M
$120K 0.02%
10,562
+4,221
+67% +$54.5K
CSTL icon
354
Castle Biosciences
CSTL
$960M
$117K 0.01%
5,297
+2,187
+70% +$47.6K
MDB icon
355
MongoDB
MDB
$35.2B
$117K 0.01%
326
+185
+131% +$75.6K
PHAT icon
356
Phathom Pharmaceuticals
PHAT
$742M
$117K 0.01%
10,989
+4,363
+66% +$37.1K
EDIT icon
357
Editas Medicine
EDIT
$436M
$117K 0.01%
15,713
+6,263
+66% +$52K
APH icon
358
Amphenol
APH
$210B
$116K 0.01%
2,000
– –
ANAB icon
359
AnaptysBio
ANAB
$1.69B
$115K 0.01%
5,123
+2,051
+67% +$48.6K
TTWO icon
360
Take-Two Interactive
TTWO
$45.4B
$114K 0.01%
769
+430
+127% +$66.8K
TRML
361
DELISTED
Tourmaline Bio
TRML
$113K 0.01%
4,939
+2,582
+110% +$91K
TVTX icon
362
Travere Therapeutics
TVTX
$5.86B
$113K 0.01%
14,652
+5,962
+69% +$50.3K
LXRX icon
363
Lexicon Pharmaceuticals
LXRX
$1.05B
$113K 0.01%
46,930
+18,601
+66% +$40K
FULC icon
364
Fulcrum Therapeutics
FULC
$284M
$112K 0.01%
11,916
+4,766
+67% +$42.5K
ALEC icon
365
Alector
ALEC
$240M
$111K 0.01%
18,403
+8,670
+89% +$56.7K
LYEL icon
366
Lyell Immunopharma
LYEL
$347M
$109K 0.01%
2,443
+986
+68% +$42.2K
ALXO icon
367
ALX Oncology
ALXO
$278M
$107K 0.01%
9,587
+3,825
+66% +$53.7K
PETQ
368
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$103K 0.01%
5,643
+2,271
+67% +$40.4K
TSHA icon
369
Taysha Gene Therapies
TSHA
$2.05B
$103K 0.01%
35,908
+14,286
+66% +$29.8K
BMEA icon
370
Biomea Fusion
BMEA
$92.8M
$103K 0.01%
6,862
+2,731
+66% +$45K
MLYS icon
371
Mineralys Therapeutics
MLYS
$2.38B
$102K 0.01%
7,931
+3,181
+67% +$39.3K
TJX icon
372
TJX Companies
TJX
$169B
$101K 0.01%
1,000
– –
HSAI
373
Hesai Group
HSAI
$2.99B
$101K 0.01%
20,000
– –
HCM icon
374
HUTCHMED
HCM
$2.13B
$99.7K 0.01%
5,933
+2,340
+65% +$35.5K
VYGR icon
375
Voyager Therapeutics
VYGR
$197M
$96.9K 0.01%
10,404
+5,311
+104% +$44.8K
13 14
15
16 17

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q1 2024 Portfolio in Review

As of Q1 2024, China Universal Asset Management Company held 459 positions worth $787M, up 53% from $514M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

China Universal Asset Management Company deployed $216M of net new capital in Q1 2024, opening 34 new positions and adding to 332 existing holdings. Its largest new stake was New Oriental: 27,235 shares worth $2.36M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard World Funds Extended Duration ETF, an estimated $3.62M trimmed.

  • China Universal Asset Management Company's largest Q1 2024 buy was New Oriental: 27,235 shares worth $2.36M.
  • China Universal Asset Management Company added most to Microsoft in Q1 2024, an estimated $17.5M increase.
  • China Universal Asset Management Company's biggest Q1 2024 reduction was Vanguard World Funds Extended Duration ETF, cutting an estimated $3.62M.
  • China Universal Asset Management Company fully exited Block Inc in Q1 2024, selling an estimated $2.4M.
  • China Universal Asset Management Company's ten largest holdings make up 30% of its $787M portfolio in Q1 2024.
  • China Universal Asset Management Company opened 34 new positions and closed 19 in Q1 2024.
  • China Universal Asset Management Company's portfolio value rose 53% quarter-over-quarter to $787M.

Based on China Universal Asset Management Company's 13F filing for Q1 2024, filed 29 Apr 2024.